What is the average price target for PETMED EXPRESS INC (PETS) stock?
6 analysts have analysed PETS and the average price target is 2.81 USD. This implies a price increase of 12.65% is expected in the next year compared to the current price of 2.49.
NASDAQ:PETS • US7163821066
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for PETMED EXPRESS INC (PETS).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-04-17 | Morgan Stanley | Maintains | Underweight -> Underweight |
| 2024-08-07 | Lake Street | Downgrade | Buy -> Hold |
| 2024-06-12 | Lake Street | Maintains | Buy -> Buy |
| 2024-06-12 | Morgan Stanley | Maintains | Underweight -> Underweight |
| 2023-11-16 | Morgan Stanley | Maintains | Underweight -> Underweight |
| 2023-10-31 | Morgan Stanley | Maintains | Underweight -> Underweight |
| 2023-10-19 | Morgan Stanley | Maintains | Underweight -> Underweight |
| 2023-07-27 | Morgan Stanley | Reiterate | Underweight -> Underweight |
| 2023-05-25 | Lake Street | Initiate | Buy |
| 2023-03-23 | Morgan Stanley | Maintains | Underweight |
| 2022-11-08 | Morgan Stanley | Maintains | Underweight |
| 2022-07-26 | Morgan Stanley | Maintains | Underweight |
| 2022-05-10 | Morgan Stanley | Maintains | Underweight |
| 2022-01-25 | Morgan Stanley | Maintains | Underweight |
| 2022-01-20 | Sidoti & Co. | Upgrade | Neutral -> Buy |
| 2021-11-18 | Morgan Stanley | Initiate | Underweight |
| 2021-10-01 | Jefferies | Initiate | Hold |
| 2021-06-03 | Sidoti & Co. | Downgrade | Buy -> Neutral |
| 2021-03-05 | Sidoti & Co. | Upgrade | Neutral -> Buy |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 256.9M -6.04% | 274.095M 6.69% | 226.972M -17.19% | 203.04M -10.54% | 209.09M 2.98% | 214.81M 2.74% | |
| EBITDA YoY % growth | 2.15M -92.44% | -1.106M -151.44% | 6.709M 706.60% | 5.7M -15.04% | 11.708M 105.40% | 12.014M 2.61% | |
| EBIT YoY % growth | -1.4M -105.45% | -8.162M -483.00% | -330K 95.96% | -5.837M -1,668.93% | 169.32K 102.90% | 475.32K 180.72% | |
| Operating Margin | -0.54% | -2.98% | -0.15% | -2.88% | 0.08% | 0.22% | |
| EPS YoY % growth | 0.02 -98.15% | -0.39 -2,050.00% | -0.30 22.00% | -0.22 26.23% | 0.01 104.55% | 0.02 100.00% |
All data in USD
| Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.13 76.50% | 0.00 100.00% | 0.10 150.00% | 0.00 100.00% | -0.09 30.77% |
| Revenue Q2Q % growth | 57.002M 22.67% | N/A | N/A | N/A | N/A |
| EBITDA Q2Q % growth | 1.499M -32.45% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -854.76K 82.27% | N/A | N/A | N/A | N/A |
All data in USD
6 analysts have analysed PETS and the average price target is 2.81 USD. This implies a price increase of 12.65% is expected in the next year compared to the current price of 2.49.
PETMED EXPRESS INC (PETS) will report earnings on 2026-06-15, after the market close.
The consensus EPS estimate for the next earnings of PETMED EXPRESS INC (PETS) is -0.13 USD and the consensus revenue estimate is 57.00M USD.
The number of analysts covering PETMED EXPRESS INC (PETS) is 6.